spectra were obtained on a Varian T-60A spectrometer at room temperature in pyridine-d; (c 0.05 g/ nil). Chemical shifts are reported in ppm from tetramethylsilane (TMS) as internal reference and coupling constants are reported in Hz. PFT 13C NMR spectra were recorded with a Varian XL-200-FT spectrometer at 50.3 MHz in proton decoupled conditions at room temperature.
Samples were dissolved in deuteriochloroform (c 0.2 g/ml) containing tetramethylsilane (TMS) as internal reference.
Thin-layer chromatography (TLC) was carried out on precoated silica gel 60 F-254 plates (Merck) using acetone -chloroform -methanol -10% ammonium hydroxide (50: 50: 1.4: 2, v/v) as developing solvent system (three runs). Compounds were visualized by spraying the plates with anisaldehydeacetic acid -methanol -sulfuric acid (1: 5:90: 2, v/v). Colors developed after a few minutes at 80°C. Antibiotics were also detected by bioautography on Micrococcus luteus ATCC 9341 seeded agar. High performance liquid chromatography (HPLC) analyses were carried out according to a modification of a described procedure').
A Hewlett-Packard 1084 B liquid chromatograph equipped with a variable-wavelength detector at 210 nm and a Lichrosorb RP8 10 trm stainless steel column, 250 x 4.6 mm i.d., was used. Flow rate of the mobile phase was 2.0 ml/minute and the column was operated at 40°C. Two mobile phases were employed: mobile phase 1 consisted of acetonitrile -0.01 M phosphate pH 7.0 (40: 60, v/v); mobile phase 2 consisted of acetonitrile -0.01 M phosphate pH 7.0 (64: 36, v/v). Gas liquid chromatographies (GLC) were carried out on a Perkin Elmer Model 900 B equipped with a glass column, 2,500 x 2 mm i.d., packed with 4.3 % Silicone OV 25 on 100 -120 mesh HP Chromosorb W and heated from 100'C to 160°C (6`C/minute).
Nitrogen gas was used as a carrier at 30 ml/minute and 2.8 kg/cm2 inlet pressure.
Column Chromatography Partition column chromatographies were carried out in conformity with a reported method") using Silica gel 60, 70230 mesh (Merck). Fifteen-milliliter fractions were collected at a flow rate of 1.0 ml per minute. Residual buffer salts were removed from products by washing their chloroform solutions with water. Sephadex LH-20 (Pharmacia Fine Chemicals), particle size 25 -100 tim, was refluxed for 30 minutes three times in a mixture of chloroform and methanol (1: 1, v/v), filtered, and dried at 40°C before being used for column chromatography" Materials Erythronolide B was isolated from the fermentation broth of Strepton:yces erythraeus LMC 1192, a completely blocked mutant which accumulates large quantities of this compound. Isolation and fermentation procedures were as reported elsewhere').
Erythromycin B was prepared from crude erythromycin A as described previously"). Oleandomycin was purified from a commercial product by crystallization from methanol -water. Mutagenesis S. antibioticus spore cells from yeast malt extract (YME) slant culture were suspended in 10 ml of saline containing 0.1 % Tween 80 and dispersed by vortexing with glass beads. After filtration through Whatman No. 1 paper, the spores were centrifuged and resuspended at a density of 1 -5 x 101 cells/ml in 10 ml of saline in Petri dish, to be irradiated by UV light (emission maximum at 254 nm). The dosage was such as to kill 99.6 % of the spores (about 3,000 erg/cm2). Survivors were plated on YME agar and incubated for 5 days at 33°C.
Antibacterial Activity Minimal inhibitory concentrations (MIC) were determined by a standard agar-diffusion well technique. The MICs were the lowest concentrations of antibiotics in a two-fold serial dilution which still showed inhibitory activity.
Experiments and Results

Isolation of the Converting Strain
Survivors of the UV mutagenic treatment of an industrial oleandomycin-producing strain were subjected to a two steps screening program, first employing the agar piece method") for selection of completely blocked mutants, which thereafter were tested for antibiotic cosynthesis on YME agar") together with S. erythraeus LMC 1192 as the erythronolide B producing strain. When the completely blocked mutant S. antibioticus LMC 1163 (registered as ATCC 31771) was tested in these conditions, antibiotic activity was found in the middle region of the plate. A small agar disk froth this region was applied to a TLC plate according to a previously described agarchromatographic technique''), and four different active compounds were detected by bioautography of the developed plate (Fig. 1 ).
Conversion Experiment in Liquid Culture
In order to obtain appreciable quantities of 
Isolation of Fermentation Products
After 100-hour fermentation, the broth pooled from 130 flasks was filtered through Celite, and S. erythraeus LMC 1192 (strain A), erythronolide B producer, and S. antibioticus ATCC 31771 (strain B) were streaked over opposite halves of a Petri dish, 1 -2 mm apart, on YME agar (a). Following incubation for 5 days at 33'C, agar cylinders were picked up with a cork borer and applied on a TLC plate").
Results of further development and bioautography of the plate are shown in (b). Samples 1, 2, 3 came from the corresponding regions in the Petri dish. See Analyticals for details of TLC. prove the structures of the compounds I and IV. As for erythromycin B'0>, a solution of compound I in glacial acetic acid was allowed to stand at room temperature for two hours and processed as already reported" to give a white foam, whose UV absorption was compatible with the previously assigned "8 ,9-anhydro-6,9-hemiketal" structure"). Treatment of compound I with acetic anhydride in pyridine'") yielded a tetraacetyl derivative. Moreover, the mild acetylation of I smoothly produced a monoacetyl ester from which the parent was regenerated by mild treatment with methanol'3>. These acetates were characterized by their 1H NMR spectra.
Comparison of UV, IR and 1H NMR spectra of compounds I and II clearly showed their similarity.
The 1H NMR spectrum of I revealed additional resonances attributable to methylene protons, but chemical shift and complex spin pattern made the analysis by inspection no longer possible. However, by comparing the 13C NMR chemical shifts of compound II and erythromycin B with the corresponding chemical shifts of compound I, oxidation of the 14-CH, group was clearly evidenced. In fact, the carbon resonance at 10.4 ppm, attributed to 14-CH, both in erythromycin B and compound II, was absent in the spectrum of compound I. The signal at 58.9 ppm was assigned to the C-15 methylene group. A substantial downfield a-shift (48.5 ppm) of the carbon previously part of the 14-CH, group, and a modest downfield ~-shift (10.3 ppm) of the C-14 carbon were observed. These shift magnitudes were consistent with the published substituent effects of replacement of a proton by a primary hydroxyl groupL4'.
Upfield ;--shift of 4.6 ppm (when compared with the spectrum of erythromycin B) was also observed for C-13. Other small changes between chemical shifts of compounds I and II were likely a consequence of both altered structure and slight conformational difference. All available spectroscopic data sup-ported that the structure of compound I was 3-O-oleandrosyl-5-O-desosaminyl-l5-hydroxyerythronolide B.
As for oleandomycin''', treatment of compound IV with anhydrous hydrochloric acid yielded a chlorohydrin (mp 169 -170'C from ethyl acetate. , which by addition of two equivalents of sodium hydroxide was converted to the same product obtained by hydrolysis of IV in dilute hydrochloric acid. This reaction was monitored by HPLC (mobile phase 2). In analogy to oleandomycin, compound IV did not show any reaction when treated with glacial acetic acid at room temperature for two hours. Treatment of compound IV with acetic anhydride in Table 1 . "C Chemical shifts, of compounds 1, II, III, IV, erythromycin B1"•°''',') and oleandomycin=" . Table 1 .
Acid Stability
The acid stability at 25°C of compounds I, II, III, IV and related erythromycin A were compared by HPLC analysis (mobile phase 2) using 0.1 solutions in buffers at pH 2, 3, 4, as described in Table 2 . In contrast to erythromycin A which rapidly decomposes in acid solution to yield the biologically inactive anhydroerythromycin2'), the new compounds I, II, III, IV are remarkably stable in the acid environment. Table 2 . Acid stability at 25°C. Biological Activity
The activity of the compounds I, II, III, IV was established against a variety of bacteria; erythromycin A, erythromycin B and oleandomycin were used as control compounds (Table 3 
Discussion
Four new antibiotics, whose structures are reported in Scheme 1, were obtained by feeding ery- xylated at C-15 to yield compound I, or converted, via compound III, to compound IV (Fig. 2) . The former pathway is not induced unless glucose is present in the medium (R. SPAGNOLI, unpublished results). The latter route suggests that a corresponding sequence could lead to epoxide formation in the still largely unknown oleandomycin biosynthesis. The hypothesis221) that the insertion of the "extra" hydroxyl groups in macrolide aglycones biosynthesis, such as that at C-8 of oleandomycin, is a late biochemical event occurring with retention of the original stereochemistry, is confirmed by our results. The use of unnatural substrates could be an interesting tool in elucidating biosynthetic pathways, inasmuch as they introduce some rate limitations in the sequence of enzymatic reactions.
As a consequence, intermediate products may accumulate which would otherwise remain undetected. On the other hand we lack an adequate explanation for compound I production, as no other methyl-hydroxylation in a corresponding position is known to occur for 14-membered macrolides. We excluded that this compound was obtained due to biochemical abnormality of the employed mutant, because many other independently selected mutants also produced it (R. SPAGNOLI, unpublished results).
Furthermore, the hypothesis") of product formation by non-specific enzymes released by old lysing mycelia was not consistent with the early appearance of compound I, and its quite large quantity in the fermentation broth. This new C-15 hydroxyl substituent, however obtained, offers opportunities for further chemical modifications of the corresponding antibiotic aimed to improve the microbiological activity. Activity in vitro was lower than erythromycins A and B for all four new antibiotics, as expected with oleandrose substituting cladinose5 . The better antibacterial activity of compound IV as compared to oleandomycin indicates that C-6 hydroxyl and C-13 ethyl groups may be important for activity in the erythromycin series.
Comparison between compounds II and III shows that the antimicrobial activity is negatively affected when hydrogen at C-8 is replaced by a hydroxyl group, as previously reported for erythromycins A31,321 and B12,16) A very pronounced acid stability, which can be related to the neutral sugarb) and possibly also to the aglycone structure, is the main feature of these new antibiotics which encourages us to further investigate them in vivo.
